Due to stockholders for redemption of common stock
68,652,349
Accrued offering costs
0
Total current liabilities
72,436,058
Deferred underwriting fee payable
2,518,500
Total liabilities
74,954,558
Accumulated deficit
-6,112,830
Common stock, 0.0001 par value 50,000,000 shares authorized, 1,967,000 shares issued and outstanding (excluding 422,025 and 6,900,000 shares subject to possible redemption) as of june 30, 2025 and december 31, 2024, respectively
197
Additional paid-in capital
0
Total stockholders deficit
-6,112,633
Common stock subject to possible redemption, 422,025 and 6,900,000 shares at redemption value of 10.61 and 10.41 per share as of june 30, 2025 and december 31, 2024, respectively
4,479,394
Total liabilities and stockholders deficit
73,321,319
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.